NCT00084669View on ClinicalTrials.gov

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

NACompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2010

Conditions

Breast CancerHot FlashesSleep Disorders

Interventions

DRUG

venlafaxine

DRUG

zolpidem tartrate

PROCEDURE

management of therapy complications

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115-6084

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT00084669 - Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer | Biotech Hunter | Biotech Hunter